Detalhe da pesquisa
1.
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.
Cancer Immunol Res
; 12(3): 322-333, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147316